CQC’s new primary care framework: What GP practices should do now
CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.
Life science research
With many life sciences breakthroughs and increasing demand for new technology from various sectors, the life sciences sector is full of exciting opportunities.
As specialists in supporting life science businesses, we know there are also challenges to overcome in commercialising innovations. You might need help raising finance for research or product development, or perhaps you’re looking for advice on financial compliance or commercial strategy.
Advice where and when you need it
Our specialist life sciences team offers a range of business services focused specifically on the needs of life sciences companies. These include:
- tax-efficient fundraising and initial public offerings
- outsourced accountancy, bookkeeping and secondments
- growth and exit planning
- business planning and forecasting
- corporate finance
- tax and VAT planning
- audit and assurance services
- share scheme implementation
- R&D tax reliefs and patent box claims
We want to help you succeed
We have supported many clients – including life sciences clients – through challenging times. However, looking forward, we are excited for what the future holds for companies and individuals situated within this industry.
The last couple of years has strengthened the reputation of the life sciences industry as being an inventive and adaptable industry due to the growth the industry experienced during the pandemic.
The question remains around how life science companies will sustain this high level of growth and continue to accelerate forward whilst their attention is focused on increasing revenue and profits, and sustaining their competitive advantage. Life sciences companies will also be determined by:
- their balance sheet strength from which to invest,
- retaining a highly skilled workforce,
- shareholder belief in strong returns on capital in an appropriate time horizon
- ESG, sustainability, and accountability
- their ability to fully integrate digitalisation
We can help
Contact us today to find out more about how we can help you
Read our insights here
Price Bailey supports NRG Therapeutics’ transition to clinical-stage biotech
How Price Bailey supports NRG Therapeutics with investor-led audit and governance advice as it transitions from discovery-stage research to clinical development...
Company valuation webinar series
Stay up-to-date with the data and stories emerging from UK valuations.
Contentious Tax Bulletin
Tax Investigations Partner, Andrew Park, provides a round up of the most recent and significant contentious tax news. Read more here...